NAPLES, Fla., Sept. 20, 2019 /PRNewswire/ -- The Florida Medical Cannabis Conference & Exhibition (FMCCE 2020) will be held June 26 - 28, 2020, at the Naples Grand Beach Resort in Naples, Florida. This conference is a networking and educational forum on the subject of medical cannabis.
This conference is designed for attendees who are active or interested in the medical cannabis industry.
For medical professionals and entrepreneurs, the conference will cover a range of topics, all relevant to the medical cannabis industry, as it pertains to the State of Florida, including but not limited to:
Government Regulation & Policies
Anticipated Reform
Cultivation
Processing
Dispensing
Legal Concerns
Emerging Topics
Running a Medical Cannabis Business
For medical professionals, topics will include:
Introduction to Cannabis as Medicine
Research for Specific Medical Conditions
Symptoms and Diagnosis
Proper Dosage
Contraindications & Drug Interactions
"Education is the key to raising awareness of the clinical uses for medical cannabis." said Ron Watson, CEO of Watson Strategies. "This conference will provide a forum for industry leaders to expand their social capital, and healthcare professionals to expand their knowledge about medical benefits and applications."
Those that should consider attending include:
Advocacy Groups
City and County Commissions
Entrepreneurs
Equipment Suppliers
Insurance Providers
Investment Bankers and Venture Capitalist
Legal Experts
Legislators
Lobbyists
Cannabis growers and distributors
Media
Medical/Clinical Researchers and Students
Physicians
Regulators
Trade Associations
For information on submitting an abstract for an oral or poster presentation, becoming a sponsor, or exhibiting please visit the conference web site at: http://www.fmcce.org
SOURCE The Florida Medical Cannabis Conference & Exhibition
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit:
All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...